Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Adult male subjects, at least 18 years of age, who are willing to participate in the study
Participants who experienced abrupt visual loss in one eye (defined as typically less than a 1-day period or visual loss noted upon awakening) and presented for an initial visit within 45 days of onset of NAION symptoms to an ophthalmologist that resulted in a diagnosis of Suspected NAION by the investigator
You may not be if
Previous history of NAION
Previous history of arteritis (anywhere in the body) or clinical or diagnostic testing evidence of temporal arteritis
History of glaucoma in either one or both eyes
History of multiple sclerosis or diagnostic testing evidence of optic neuritis
Have dementia or other reasons for memory impairment in the opinion of the investigator
Have participated in other non-observational studies within 3 months of NAION onset
Clareo Health | A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
